Collegium Pharmaceutical (COLL) Other Operating Expenses (2016 - 2026)

Collegium Pharmaceutical has reported Other Operating Expenses for 6 years, with the latest figure at -$1.8 million in Q2 2026.

• On a quarterly basis, Other Operating Expenses rose 83.96% year-over-year to -$1.8 million in Q2 2026; TTM through Jun 2026 was -$13.2 million, a 71.66% increase from a year earlier, with the FY2025 full-year figure at -$5.4 million, up 86.75% from the prior year.
• Other Operating Expenses was -$1.8 million for Q2 2026 at Collegium Pharmaceutical, down from -$463000.0 in the prior quarter.
• The five-year high for Other Operating Expenses was -$19000.0 in Q4 2025, with the low at -$15.2 million in Q1 2025.
• Average Other Operating Expenses over 3 years is -$7.6 million, with a median of -$8.2 million recorded in 2024.
• The largest YoY upside for Other Operating Expenses was 99.85% in 2025 against a maximum downside of 75.88% in 2025.
• Over 3 years, Other Operating Expenses stood at -$12.4 million in 2024, then soared by 99.85% to -$19000.0 in 2025, then plunged by 9436.84% to -$1.8 million in 2026.
• The last three Other Operating Expenses figures came in at -$1.8 million (Q2 2026), -$463000.0 (Q1 2026), and -$19000.0 (Q4 2025), per Business Quant data.